MOHAMMAD ASIM NISAR: Open Payments
NPI 1437444791 · OKEECHOBEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,666 in 35 payments from 7 companies in 2025. Trend: 2023 $46,581 · 2024 $39,034 · 2025 $24,666
Speaker / faculty: $20,588Travel & lodging: $2,952Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $24,093 |
| Alkermes, Inc. | 8 | $234 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $102 |
| Axsome Therapeutics, Inc. | 1 | $79 |
| Teva Pharmaceuticals USA, Inc. | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: REXULTI, LYBALVI, ARISTADA, COBENFY, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
